Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trialBrent A. Neuschwander‐Tetri, Edward Doo, Anna Mae Diehl et al.|The Lancet|2014Cited by 2.2k
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡Kittichai Promrat, Jay H. Hoofnagle, Glen Lutchman et al.|Hepatology|2004Cited by 724
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver DiseaseMohammad Shadab Siddiqui, Arun J. Sanyal, Raj Vuppalanchi et al.|Clinical Gastroenterology and Hepatology|2018Cited by 593
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CAlejandro Soza, Jay H. Hoofnagle, Marc G. Ghany et al.|Hepatology|2002Cited by 216